Daniel Bednarik’s Background
IN MY CURRENT POSITION OF SENIOR DIRECTOR, MOLECULAR ENGINEERING UNIT (MEU) OPERATIONS, I provide molecular engineering support for the company’s programs and “External Channel Partner” collaborations in terms of proprietary gene design technology needs to facilitate drug and/or product development across a spectrum of corporate divisions and sectors. Works closely with the Chief Scientific Officer (MEU), President, Human Therapeutics Division (HTD), and the Cell Engineering Unit (CEU) to accelerate translation of technology to application in the clinic or other venues.
Key areas include:
- Construction of orally inducible gene therapy solutions – biologic, RNAi.
- Novel delivery of gene therapy solutions – viral, nonviral, nanoparticle.
- Novel cell-based production platform development.
- Veterinary, food science, health sector, bioinformatics, and other.
Specialties:Recruitment of private capital, Bioinformatics/Genomics, Clinical Program Development & Management, Pharmacogenomics, Virology, Translational Medicine, Heart Disease.
Please visit my LinkedIn Profile – http://www.linkedin.com/in/danielpbednarikdanielbednarik